We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 3,516 results
  1. GRAMM Web Server for Protein Docking

    Prediction of the structure of protein complexes by docking methods is a well-established research field. The intermolecular energy landscapes in...
    Amar Singh, Matthew M. Copeland, ... Ilya A. Vakser in Computational Drug Discovery and Design
    Protocol 2024
  2. Molecular Dynamics Simulation-Based Prediction of Glycosaminoglycan Interactions with Drug Molecules

    Glycosaminoglycans (GAGs) are a class of long linear anionic periodic polysaccharides. Their biological activities are very broad including tissue...
    Martyna Maszota-Zieleniak, Sergey A. Samsonov in Computational Drug Discovery and Design
    Protocol 2024
  3. Detection of Beta-Glucan Contamination in Nanoparticle Formulations

    Beta-glucans with diverse chemical structures are produced by a variety of microorganisms and are commonly found in microbial cell walls....
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  4. Advancements in Nanoparticle Characterization

    Nanotechnology for drug delivery has made significant advancements over the last two decades. Innovations have been made in cancer research and...
    Rachael M. Crist, Jeffrey D. Clogston, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  5. Detection of Nanoparticle-Mediated Total Oxidative Stress in T Cells Using CM-H2DCFDA Dye

    Oxidative stress is commonly observed in cells following exposure to nanoparticles. Both negative (e.g., cytotoxicity and inflammation) and...
    Ankit Shah, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  6. Analysis of Nanoparticles’ Effects on Drug-Induced Psoriasis

    Psoriasis, an auto-inflammatory disorder, has major manifestations in the skin but can affect other organs. Currently, this condition has no cure,...
    Ankit Shah, Chelsea Sanders, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  7. Detection of Nanoparticle-Mediated Change in Mitochondrial Membrane Potential in T Cells Using JC-1 Dye

    Alterations in mitochondrial membrane potential are associated with the generation of reactive oxygen species and cell death. While eliminating...
    Ankit Shah, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  8. Analysis of Nanoparticles’ Potential to Induce Autoimmunity

    Autoimmune responses are characterized by the presence of antibodies and lymphocytes specific to self or so-called autoantigens. Among such...
    Barry W. Neun, Timothy M. Potter, ... Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  9. Antigen-Specific Stimulation of CD8+ T Cells by Murine Bone Marrow–Derived Dendritic Cells After Treatment with Nanoparticles

    The assessment of antigen presentation by dendritic cells and subsequent antigen-dependent activation of T lymphocytes is a critical step underlying...
    En** Hong, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  10. In Vitro and In Vivo Methods for Analysis of Nanoparticles' Potential to Induce Delayed-Type Hypersensitivity Reactions

    Delayed-type hypersensitivity (DTH) reactions are among the common reasons for drug withdrawal from clinical use during the post-marketing stage....
    Timothy M. Potter, Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  11. Immunophenoty**, Part II: Analysis of Nanoparticle Effects on the Composition and Activation Status of Human Peripheral Blood Mononuclear Cells

    The use of nanoparticles as drug delivery carriers requires analysis of their safety, which among other tests, includes immunotoxicity. Nanoparticles...
    Hannah S. Newton, Jenny Zhang, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  12. Assessment of Protein Binding Using Asymmetric-Flow Field-Flow Fractionation Combined with Multi-angle Light Scattering and Dynamic Light Scattering

    Asymmetric-flow field-flow fractionation (AF4) is a valuable tool to separate and assess different size populations in nanotherapeutics. When coupled...
    Matthew Hansen, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  13. Nanoparticle Size Distribution and Stability Assessment Using Asymmetric-Flow Field-Flow Fractionation

    Nanomaterials are inherently polydisperse. Traditional techniques, such as the widely used batch-mode dynamic light-scattering (DLS) analysis, are...
    Matthew Hansen, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  14. Analysis of Nanoparticle Adjuvant Properties

    Nanoparticles can be engineered for targeted antigen delivery to immune cells and for stimulating an immune response to improve the antigen...
    Barry W. Neun, Edward Cedrone, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  15. Evaluation of Nanomedicine Tissue Distribution and Stability by Alexa Fluor 488 and PEG Immunohistochemistry

    A primary issue with nanomedicine biological evaluation is determination of nanoparticle carrier tissue distribution and stability. Here we present a...
    Teagan D. Ware, Donna Butcher, ... Stephan T. Stern in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  16. Current Considerations and Practical Solutions for Overcoming Nanoparticle Interference with LAL Assays and Minimizing Endotoxin Contamination

    Monitoring endotoxin contamination in drugs and medical devices is required to avoid pyrogenic responses and septic shock in patients receiving these...
    Barry W. Neun, Marina A. Dobrovolskaia in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  17. Quantitation of Active Pharmaceutical Ingredients in Polymeric Drug Products Using Elemental Analysis

    Polymeric prodrugs have gained significant popularity as a strategy to enhance the bioavailability and improve the pharmacokinetic properties of...
    Jie Xu, Yingwen Hu, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  18. A Static Headspace Gas Chromatography Method for Quantitation of Residual Solvents in Nanoformulations

    Various organic solvents are widely used in the manufacturing, processing, and purification of drug substances, drug products, formulations,...
    Krishna Kattel, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  19. Assessment of Temperature-Dependent Drug Release of Solubilizing Nanoformulations Using the SITUA

    The evaluation of temperature-dependent drug release for solubilizing nanoformulations uses a modification of the stable isotope ultrafiltration...
    Stephan T. Stern, Sarah L. Skoczen, Young Hwan Park in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
  20. Particle Size and Concentration Measurement Using the Spectradyne nCS1 Instrument

    This protocol describes the use of the Spectradyne nCS1 instrument to measure the particles per mL concentration and size of nanoparticles. The...
    Alison Vermilya, Jeffrey D. Clogston in Characterization of Nanoparticles Intended for Drug Delivery
    Protocol 2024
Did you find what you were looking for? Share feedback.